{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T20:15:55Z","timestamp":1781554555910,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00408-024-00746-7","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T03:09:35Z","timestamp":1727060975000},"page":"785-792","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Factors Associated with Corticosteroid Adherence in Sarcoidosis"],"prefix":"10.1007","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4663-7985","authenticated-orcid":false,"given":"Marc A.","family":"Judson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wende Ouedraogo","family":"Ouedraogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth M.","family":"Fish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"DeLuca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"VanCavage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnaveni","family":"Sirigaddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Recai","family":"Yucel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"issue":"1","key":"746_CR1","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.chest.2020.01.026","volume":"158","author":"M Sharp","year":"2020","unstructured":"Sharp M, Brown T, Chen ES, Rand CS, Moller DR, Eakin MN (2020) Association of medication adherence and clinical outcomes in sarcoidosis. Chest 158(1):226\u2013233","journal-title":"Chest"},{"issue":"1","key":"746_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.chest.2020.03.001","volume":"158","author":"MA Judson","year":"2020","unstructured":"Judson MA (2020) Causes of poor medication adherence in sarcoidosis: poor patient-doctor communication and suboptimal drug regimens. Chest 158(1):17\u201318","journal-title":"Chest"},{"key":"746_CR3","doi-asserted-by":"publisher","first-page":"15026","DOI":"10.1038\/npjpcrm.2015.26","volume":"25","author":"V Cooper","year":"2015","unstructured":"Cooper V, Metcalf L, Versnel J, Upton J, Walker S, Horne R (2015) Patient-reported side effects, concerns and adherence to corticosteroid treatment for asthma, and comparison with physician estimates of side-effect prevalence: a UK-wide, cross-sectional study. NPJ Prim Care Respir Med 25:15026","journal-title":"NPJ Prim Care Respir Med"},{"issue":"12","key":"746_CR4","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/j.crohns.2014.08.013","volume":"8","author":"R Mountifield","year":"2014","unstructured":"Mountifield R, Andrews JM, Mikocka-Walus A, Bampton P (2014) Covert dose reduction is a distinct type of medication non-adherence observed across all care settings in inflammatory bowel disease. J Crohns Colitis 8(12):1723\u20131729","journal-title":"J Crohns Colitis"},{"issue":"4","key":"746_CR5","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1111\/j.1365-2133.2010.09877.x","volume":"163","author":"C Arena","year":"2010","unstructured":"Arena C, Morin AS, Blanchon T et al (2010) Impact of glucocorticoid-induced adverse events on adherence in patients receiving long-term systemic glucocorticoid therapy. Br J Dermatol 163(4):832\u2013837","journal-title":"Br J Dermatol"},{"issue":"2","key":"746_CR6","first-page":"119","volume":"29","author":"MA Judson","year":"2012","unstructured":"Judson MA, Boan AD, Lackland DT (2012) The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. Sarcoidosis Vasc Diffuse Lung Dis 29(2):119\u2013127","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"746_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2021.106622","volume":"189","author":"J Simmering","year":"2021","unstructured":"Simmering J, Stapleton EM, Polgreen PM, Kuntz J, Gerke AK (2021) Patterns of medication use and imaging following initial diagnosis of sarcoidosis. Respir Med 189:106622","journal-title":"Respir Med"},{"key":"746_CR8","doi-asserted-by":"publisher","unstructured":"Baughman RP, Valeyre D, Korsten P et al (2021) ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J 58(6):2004079. https:\/\/doi.org\/10.1183\/13993003.04079-2020","DOI":"10.1183\/13993003.04079-2020"},{"issue":"5","key":"746_CR9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1056\/NEJMra050100","volume":"353","author":"L Osterberg","year":"2005","unstructured":"Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353(5):487\u2013497","journal-title":"N Engl J Med"},{"issue":"8","key":"746_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1164\/rccm.202002-0251ST","volume":"201","author":"ED Crouser","year":"2020","unstructured":"Crouser ED, Maier LA, Wilson KC et al (2020) Diagnosis and detection of sarcoidosis. An official american thoracic society clinical practice guideline. Am J Respir Crit Care Med 201(8):26\u201351","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"746_CR11","first-page":"149","volume":"16","author":"GW Hunninghake","year":"1999","unstructured":"Hunninghake GW, Costabel U, Ando M et al (1999) ATS\/ERS\/WASOG statement on sarcoidosis. American thoracic Society\/European respiratory Society\/World association of sarcoidosis and other granulomatous disorders. Sarcoidosis Vasc Diffuse Lung Dis. 16(2):149\u2013173","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"issue":"1","key":"746_CR12","first-page":"19","volume":"31","author":"MA Judson","year":"2014","unstructured":"Judson MA, Costabel U, Drent M et al (2014) The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis 31(1):19\u201327","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"1","key":"746_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1164\/ajrccm.159.1.9712108","volume":"159","author":"JL Hankinson","year":"1999","unstructured":"Hankinson JL, Odencrantz JR, Fedan KB (1999) Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 159(1):179\u2013187","journal-title":"Am J Respir Crit Care Med"},{"issue":"5261","key":"746_CR14","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1136\/bmj.2.5261.1165","volume":"2","author":"JG Scadding","year":"1961","unstructured":"Scadding JG (1961) Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years\u2019 observation. Br Med J 2(5261):1165\u20131172","journal-title":"Br Med J"},{"issue":"3","key":"746_CR15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0920-9964(99)00130-9","volume":"42","author":"K Thompson","year":"2000","unstructured":"Thompson K, Kulkarni J, Sergejew AA (2000) Reliability and validity of a new medication adherence rating scale (MARS) for the psychoses. Schizophr Res 42(3):241\u2013247","journal-title":"Schizophr Res"},{"issue":"2","key":"746_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.genhosppsych.2003.08.010","volume":"26","author":"CM Van der Feltz-Cornelis","year":"2004","unstructured":"Van der Feltz-Cornelis CM, Van Oppen P, Van Marwijk HW, De Beurs E, Van Dyck R (2004) A patient-doctor relationship questionnaire (PDRQ-9) in primary care: development and psychometric evaluation. Gen Hosp Psychiatry 26(2):115\u2013120","journal-title":"Gen Hosp Psychiatry"},{"issue":"1","key":"746_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0022-3999(96)00216-4","volume":"42","author":"C Herrmann","year":"1997","unstructured":"Herrmann C (1997) International experiences with the hospital anxiety and depression scale\u2013a review of validation data and clinical results. J Psychosom Res 42(1):17\u201341","journal-title":"J Psychosom Res"},{"issue":"10","key":"746_CR18","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.euroneuro.2012.02.008","volume":"22","author":"RE Nielsen","year":"2012","unstructured":"Nielsen RE, Lindstr\u00f6m E, Nielsen J, Levander S (2012) DAI-10 is as good as DAI-30 in schizophrenia. Eur Neuropsychopharmacol 22(10):747\u2013750","journal-title":"Eur Neuropsychopharmacol"},{"key":"746_CR19","first-page":"2220","volume":"42","author":"R Horne","year":"1999","unstructured":"Horne R, Weinman J, Hankins M (1999) The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 42:2220\u20132230","journal-title":"Psychol Health"},{"issue":"7","key":"746_CR20","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1164\/rccm.201410-1785OC","volume":"191","author":"MA Judson","year":"2015","unstructured":"Judson MA, Mack M, Beaumont JL, Watt R, Barnathan ES, Victorson DE (2015) Validation and important differences for the sarcoidosis assessment tool. A new patient-reported outcome measure. Am J Respir Crit Care Med 191(7):786\u2013795","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"746_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0271650","volume":"18","author":"R Asiri","year":"2023","unstructured":"Asiri R, Todd A, Robinson-Barella A, Husband A (2023) Ethnic disparities in medication adherence? A systematic review examining the association between ethnicity and antidiabetic medication adherence. PLoS ONE 18(2):e0271650","journal-title":"PLoS ONE"},{"issue":"4","key":"746_CR22","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.1524-4733.2009.00677.x","volume":"13","author":"P Hagell","year":"2010","unstructured":"Hagell P, Hedin PJ, Meads DM, Nyberg L, McKenna SP (2010) Effects of method of translation of patient-reported health outcome questionnaires: a randomized study of the translation of the rheumatoid arthritis quality of life (RAQoL) instrument for sweden. Value Health 13(4):424\u2013430","journal-title":"Value Health"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-024-00746-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00408-024-00746-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-024-00746-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T13:06:32Z","timestamp":1730898392000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00408-024-00746-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["746"],"URL":"https:\/\/doi.org\/10.1007\/s00408-024-00746-7","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,23]]},"assertion":[{"value":"17 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Marc Judson grant support\u2014Mallinckrodt, Xentria, Atyr Pharmaceuticals; Wende Ouedraogo Ouedraogo, Kenneth Fish, Rob Deluca, Rachel Vancavage, Krishnaveni Sirigaddi, Recai Yucel: Nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing of interest"}},{"value":"This study was approved by the Institutional Review Board of Albany Medical College \/ Albany Medical Center. The study number is: 5919.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All study subjects signed an informed consent form that was approved by the Institutional Review Board of Albany Medical College \/ Albany Medical Center. The study number is: 5919.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable. Individual patient data cannot be determined in this manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}}]}}